The female menopause--now and in the millennium: new treatment options for a better quality of life.

Abstract	Estrogen has traditionally been the only agent effective for the prevention and treatment of post-menopausal osteoporosis. Estrogen's positive effects are often outweighed by negative ones. Newer agents provide safer alternatives that should increase compliance and improve quality of life.
Authors	C A Cefalu, C Fontenot
Journal	Comprehensive therapy (Compr Ther) Vol. 27 Issue 2 Pg. 95-103 ( 2001) ISSN: 0098-8243 [Print] United States
PMID	11430265 (Publication Type: Journal Article, Review)
Chemical References	Diphosphonates Selective Estrogen Receptor Modulators Progesterone Calcitonin
Topics	Calcitonin (therapeutic use) Diphosphonates (therapeutic use) Drug Therapy, Combination Estrogen Replacement Therapy Female Humans Middle Aged Osteoporosis, Postmenopausal (prevention & control) Progesterone (therapeutic use) Quality of Life Selective Estrogen Receptor Modulators (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!